Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices.

Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint in Europe.

Read full article from Mass Device here. 

At the BEC & ISEVS Endovascular Academy Meeting https://t.co/ZxILvylU22 join the ANGIO Mentor simulator Acute Stroke Intervention demo on by Prof. Iris Grunwald, Nov. 29, 16:00-17:00 and hands-on sessions https://t.co/xSIXwU0ILq. ANGIO Mentor https://t.co/PiI6euk9G0.

The DialogTech Chicago team really brought a feast for our team Thanksgiving potluck! We're donating proceeds from the potluck to the @FoodDepository. 🦃 🥧🍗

Learn what you should know about automation, autonomy and the database in this on-demand webinar. https://t.co/zlNNv2lHnC

VEITH has been quite an event. Don't miss out on the opportunity to stop by 3D Systems' booth #510 to demo Simbionix ANGIO Mentor endovascular training simulators https://t.co/YFQMNgfb3s. Contact us for a demo: https://t.co/4hiwCXW1cO #VEITH2019 #simulation #endovascular